(Q47940010)

6 February 2018

title

Therapy of hyperlipidemia with lovastatin in kidney transplant patients on cyclosporine A immunosuppression: three-year experience. (English)

1 reference

6 February 2018

1 reference

1 reference

1 reference

Kandus A

1

1 reference

6 February 2018

Kovac D

2

1 reference

6 February 2018

Cerne D

3

1 reference

6 February 2018

Koselj M

4

1 reference

6 February 2018

Kaplan-Pavlovcic S

5

1 reference

6 February 2018

Buturović J

6

1 reference

6 February 2018

Ponikvar R

7

1 reference

6 February 2018

Kveder R

8

1 reference

6 February 2018

Lindic J

9

1 reference

6 February 2018

Bren AF

10

1 reference

6 February 2018

language of work or name

English

0 references

publication date

1 June 1998

1 reference

6 February 2018

Transplantation Proceedings

published in

1 reference

6 February 2018

volume

30

1 reference

6 February 2018

issue

4

1 reference

6 February 2018

page(s)

1307-1309

1 reference

6 February 2018

Acute myocardial infarction in renal transplant recipients: incidence and prognosis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900253-X

7 January 2021

Hyperlipidemia After Renal Transplantation: Natural History and Pathophysiology

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900253-X

7 January 2021

Persistent hyperlipidemia in renal transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900253-X

7 January 2021

Lipid abnormalities in cyclosporine-prednisone-treated renal transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900253-X

7 January 2021

Hyperlipidemia in Stable Renal Transplant Recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900253-X

7 January 2021

Hyperlipidemia in renal transplant recipients: natural history and response to treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900253-X

7 January 2021

Risk factors for accelerated atherosclerosis in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900253-X

7 January 2021

Treatment of hyperlipidemia in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900253-X

7 January 2021

Therapeutic response to lovastatin (mevinolin) in nonfamilial hypercholesterolemia. A multicenter study. The Lovastatin Study Group II

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900253-X

7 January 2021

HMG-CoA reductase inhibitors for treatment of hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900253-X

7 January 2021

Efficacy and long-term adverse effect pattern of lovastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900253-X

7 January 2021

Myolysis and acute renal failure in a heart-transplant recipient receiving lovastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900253-X

7 January 2021

Rhabdomyolysis in patients receiving lovastatin after cardiac transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900253-X

7 January 2021

Rhabdomyolysis and renal injury with lovastatin use. Report of two cases in cardiac transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900253-X

7 January 2021

Lovastatin treatment of hypercholesterolemia in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900253-X

7 January 2021

Treatment of hyperlipidemic kidney graft recipients with lovastatin: effect on LDL-cholesterol and lipoprotein (a)

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900253-X

7 January 2021

10.1016/S0041-1345(98)00253-X

Identifiers

DOI

1 reference

6 February 2018

PubMed ID

9636530

1 reference

6 February 2018